Austin D. Kim - Apr 29, 2023 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
EVP,General Counsel, Secretary
Signature
/s/ Austin D. Kim
Stock symbol
ACAD
Transactions as of
Apr 29, 2023
Transactions value $
-$19,422
Form type
4
Date filed
5/2/2023, 07:06 PM
Previous filing
Apr 7, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +3.01K +12.83% 26.4K Apr 29, 2023 Direct F1
transaction ACAD Common Stock Sale -$19.4K -917 -3.47% $21.18 25.5K May 1, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -3.01K -100% $0.00* 0 Apr 29, 2023 Common Stock 3.01K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
F2 The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
F3 The restricted stock units vest in four equal annual installments beginning 4/29/2020.